Difference between revisions of "Talk:Urinary bladder"
Jump to navigation
Jump to search
(Created page with "ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329164/") |
|||
| Line 1: | Line 1: | ||
ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance | ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance | ||
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329164/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329164/ | ||
==Cancer Hotspot Panel v2== | |||
https://www.thermofisher.com/order/catalog/product/4475346 | |||
http://assets.thermofisher.com/TFS-Assets/CSD/Reference-Materials/cms_106003.csv | |||
Latest revision as of 21:41, 25 October 2018
ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329164/
Cancer Hotspot Panel v2
https://www.thermofisher.com/order/catalog/product/4475346 http://assets.thermofisher.com/TFS-Assets/CSD/Reference-Materials/cms_106003.csv